Altered expression of tissue remodeling genes in a mouse model of acute allergic rhinitis

International Forum of Allergy and Rhinology

Volumn 1, Issue 4, 2011, Pages 262-267

  Sautter, Nathan B ^a   Delaney, Katherine L ^b   Trune, Dennis R ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Allergic rhinitis; BMP; FGF; MMP; Mouse model; Tissue remodeling

Indexed keywords

FUNGAL EXTRACT; MESSENGER RNA; BONE MORPHOGENETIC PROTEIN; FIBROBLAST GROWTH FACTOR; FUNGUS ANTIGEN; NEUTROPHIL COLLAGENASE;

ALLERGIC RHINITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPERGILLUS FUMIGATUS; BONE MORPHOGENETIC PROTEIN 1 GENE; BONE MORPHOGENETIC PROTEIN 10 GENE; BONE MORPHOGENETIC PROTEIN 2 GENE; BONE MORPHOGENETIC PROTEIN 3 GENE; BONE MORPHOGENETIC PROTEIN 4 GENE; BONE MORPHOGENETIC PROTEIN 5 GENE; BONE MORPHOGENETIC PROTEIN 6 GENE; BONE MORPHOGENETIC PROTEIN 7 GENE; BONE MORPHOGENETIC PROTEIN 8A GENE; BONE MORPHOGENETIC PROTEIN 8B GENE; BONE MORPHOGENETIC PROTEIN 9 GENE; CONTROLLED STUDY; CYTOPATHOLOGY; EXPERIMENTAL MODEL; FIBROBLAST GROWTH FACTOR 1 GENE; FIBROBLAST GROWTH FACTOR 10 GENE; FIBROBLAST GROWTH FACTOR 2 GENE; FIBROBLAST GROWTH FACTOR 3 GENE; FIBROBLAST GROWTH FACTOR 4 GENE; FIBROBLAST GROWTH FACTOR 5 GENE; FIBROBLAST GROWTH FACTOR 6 GENE; FIBROBLAST GROWTH FACTOR 7 GENE; FIBROBLAST GROWTH FACTOR 8 GENE; GENE; GENE EXPRESSION; GENE FUNCTION; HISTOPATHOLOGY; INFLAMMATORY INFILTRATE; MATRIX METALLOPROTEINASE 12 GENE; MATRIX METALLOPROTEINASE 14 GENE; MATRIX METALLOPROTEINASE 1A GENE; MATRIX METALLOPROTEINASE 2 GENE; MATRIX METALLOPROTEINASE 3 GENE; MATRIX METALLOPROTEINASE 7 GENE; MATRIX METALLOPROTEINASE 8 GENE; MATRIX METALLOPROTEINASE 9 GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIZATION; ACUTE DISEASE; ANIMAL; ASPERGILLOSIS; BAGG ALBINO MOUSE; DOWN REGULATION; GENETICS; HETEROTOPIC OSSIFICATION; IMMUNOLOGY; METABOLISM; PERENNIAL RHINITIS; REAL TIME POLYMERASE CHAIN REACTION; SCAR; UPREGULATION;

ACUTE DISEASE; ANIMALS; ANTIGENS, FUNGAL; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BONE MORPHOGENETIC PROTEINS; CICATRIX; DOWN-REGULATION; FIBROBLAST GROWTH FACTORS; MATRIX METALLOPROTEINASE 8; MICE; MICE, INBRED BALB C; OSSIFICATION, HETEROTOPIC; REAL-TIME POLYMERASE CHAIN REACTION; RHINITIS, ALLERGIC, PERENNIAL; RNA, MESSENGER; UP-REGULATION;

EID: 84861118004     PISSN: 20426976     EISSN: 20426984     Source Type: Journal    
DOI: 10.1002/alr.20059     Document Type: Article

References (35)

1. Lane AP, Truong-Tran QA, Schleimer RP. Altered expression of genes associated with innate immunity and inflammation in recalcitrant rhinosinusitis with polyps. Am J Rhinol. 2006;20:138-144.
2. Ramanathan M, Lee WK, Spannhake EW, Lane AP. Th2 cytokines associated with chronic rhinosinusitis with polyps down-regulate the antimicrobial immune function of human sinonasal epithelial cells. Am J Rhinol. 2008;22:115-121.
3. Cho SH, Shin KS, Lee YS, et al. Impact of chronic rhinosinusitis and endoscopic sinus surgery on bone remodeling of the paranasal sinuses. Am J Rhinol. 2008;22:537-541.
4. Giacchi RJ, Lebowitz RA, Yee HT, Light JP, Jacobs JB. Histopathologic evaluation of the ethmoid bone in chronic sinusitis. Am J Rhinol. 2001;15:193-197.
5. Chiu AG. Osteitis in chronic rhinosinusitis. Otolaryngol Clin North Am. 2005;38:1237-1242.
6. Rudack C, Prehm P, Stoll W, Maune S. Extracellular matrix components in nasal polyposis. Acta Otolaryngol. 2003;123:643-647.
7. Khalid AN, Hunt J, Perloff JR, et al. The role of bone in chronic rhinosinusitis. Laryngoscope. 2002;112:1951-1955.
8. Kennedy DW, Senior BA, Gannon FH. Histology and histomorphometry of ethmoid bone in chronic rhinosinusitis. Laryngoscope. 1999;108:502-507.
9. Turner N, Grose R. Fibroblast growth factor signaling: from development to cancer. Nat Rev Cancer. 2010;10:116-129.
10. Parks WC, Wilson CL, Lopez-Boado YS. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol. 2004;4:617-629.
11. Rosenberg GA. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol. 2009;8:205-216.
12. Roy R, Yang J, Moses MA. Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol. 2009;31:5287-5297.
13. Mannicone AM, McGuire JK. Matrix metalloproteinases as modulators of inflammation. Semin Cell Dev Biol. 2008;19:34-41.
14. Juhasz A, Sziklai I, Rakosy Z, et al. Elevated levels of tenascin and matrix metalloproteinase 9 correlates with the bone destruction capacity of cholesteatomas. Otol Neurotol. 2009;30:559-565.
15. Jennings CR, Guo L, Collins HM, Birchall JP. Matrix metalloproteinases 2 and 9 in otitis media with effusion. Clin Otolaryngol. 2001;26:419-494.
16. Can IH, Ceylan K, Caydere M, et al. The expression of MMP-2, MMP-7, MMP-9 and TIMP-1 in chronic rhinosinusitis and nasal polyposis. Otolaryngol Head Neck Surg. 2008;139:211-215.
17. Kostamo K, Toskala E, Tervahartiala T, Sorsa T. Role of matrix metalloproteinases in chronic rhinosinusitis. Curr Opin Allergy Clin Immunol. 2008;8:21-27.
18. Bhandari A, Takeuchi K, Suzuki S, et al. Increased expression of matrix metalloproteinase-2 in nasal polyps. Acta Otolaryngol. 2004;124:1165-1170.
19. Momiyama Y, Ohmori R, Tanaka N, et al. High levels of matrix metalloproteinase-8 in patients with unstable angina. Atherosclerosis. 2010;209:206-210.
20. Li X, Meng J, Qiao X, et al. Expression of TGF, matrix metalloproteinases and tissue inhibitors in Chinese chronic rhinosinusitis. J Allergy Clin Immunol. 2010;125:1061-1068.
21. Chen YS, Langhammer T, Westhofen M, Lorenzen J. Relationship between matrix metalloproteinases MMP-2, MMP-9, tissue inhibitor of matrix metalloproteinases 1 and IL-5, IL-8 in nasal polyps. Allergy. 2007;62:66-72.
22. Bleuming SA, He XC, Kodach LL, et al. Bone morphogenetic protein signaling suppresses tumorigenesis at gastric epithelial transition zones in mice. Cancer Res. 2007;67:8149-8155.
23. Kodach LL, Wiercinska E, de Miranda NF, et al. The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers. Gastroenterology. 2008;134:1332-1341.
24. Xue T. Does bone morphogenetic proteins play an important role in chronic rhinosinusitis? Med Hypotheses. 2009;72:234.
25. Ishibashi T, Tanaka T, Nibu K, Ishimoto S, Kaga K. Keratinocyte growth factor and its receptor messenger RNA expression in nasal mucosa and nasal polyps. Ann Otol Rhinol Laryngol. 1998;107:885-890.
26. Lindsay R, Slaughter T, Britton-Webb J, et al. Development of a murine model of chronic rhinosinusitis. Otolaryngol Head Neck Surg. 2006;134:724-730.
27. Khalid AN, Woodworth BA, Prince A, et al. Physiologic alterations in the murine model after nasal fungal antigenic exposure. Otolaryngol Head Neck Surg. 2008;139:695-701.
28. Ahn BH, Park YH, Shin SH. Mouse model of Aspergillus and Alternaria induced rhinosinusitis. Auris Nasus Larynx. 2009;36:422-426.
29. Norlander T, Westrin KM, Stierna P. The inflammatory response of the sinus and nasal mucosa during sinusitis: implications for research and therapy. Acta Otolaryngol Suppl. 1994;515:38-44.
30. Bolger WE, Leonard D, Dick EJ, et al. Gram negative sinusitis: a bacteriologic and histologic study in rabbits. Am J Rhinol. 1997;11:15-25.
31. Perloff JR, Gannon FH, Bolger WE, et al. Bone involvement in sinusitis: an apparent pathway for the spread of disease. Laryngoscope. 2000;110:2095-2099.
32. Ramsebner R, Ludwig M, Parzefall T, et al. A FGF3 mutation associated with differential inner ear malformation, microtia, and microdontia. Laryngoscope. 2010;120:359-364.
33. Gamer LW, Ho V, Cox K, Rosen V. Expression and function of BMP3 during chick limb development. Dev Dyn. 2008;237:1691-1698.
34. Daluiski A, Engstrand T, Bahamonde ME, et al. Bone morphogenetic protein-3 is a negative regulator of bone density. Nat Genet. 2001;27:84-88.
35. MacArthur CJ, Hefeneider SH, Kempton JB, Trune DR. C3H/HeJ mouse model for spontaneous chronic otitis media. Laryngoscope. 2006;116:1071-1079.